Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

455 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.
Hose D, Ray S, Rößler S, Thormann U, Schnettler R, de Veirman K, El Khassawna T, Heiss C, Hild A, Zahner D, Alagboso F, Henss A, Beck S, Emde-Rajaratnam M, Burhenne J, Bamberger J, Menu E, de Bruyne E, Gelinsky M, Kampschulte M, Rohnke M, Wenisch S, Vanderkerken K, Hanke T, Seckinger A, Alt V. Hose D, et al. Among authors: hanke t. J Hematol Oncol. 2024 Dec 18;17(1):128. doi: 10.1186/s13045-024-01636-4. J Hematol Oncol. 2024. PMID: 39695697 Free PMC article.
Fluorescein-labeled stable neurotensin derivatives.
Maes V, Hultsch C, Kohl S, Bergmann R, Hanke T, Tourwé D. Maes V, et al. Among authors: hanke t. J Pept Sci. 2006 Aug;12(8):505-8. doi: 10.1002/psc.757. J Pept Sci. 2006. PMID: 16671056
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects.
Rienstra M, Tzeis S, Bunting KV, Caso V, Crijns HJGM, De Potter TJR, Sanders P, Svennberg E, Casado-Arroyo R, Dwight J, Guasti L, Hanke T, Jaarsma T, Lettino M, Løchen ML, Lumbers RT, Maesen B, Mølgaard I, Rosano GMC, Schnabel RB, Suwalski P, Tamargo J, Tica O, Traykov V, Kotecha D, Van Gelder IC. Rienstra M, et al. Among authors: hanke t. Europace. 2024 Dec 3;26(12):euae298. doi: 10.1093/europace/euae298. Europace. 2024. PMID: 39716733 Free PMC article. Review.
Safety and immunogenicity of the ChAdOx1-MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UK.
Borthwick N, Fernandez N, Hayes PJ, Wee EG, Akis Yildirim BM, Baines A, Baker M, Byard N, Conway O, Glaze M, Jenkin D, Larkworthy C, Luciw M, Platt A, Poulton I, Thomas M, Quaddy J, Watson M, Crook A, Cicconi P, Hanke T. Borthwick N, et al. Among authors: hanke t. Lancet Microbe. 2024 Nov 26:100956. doi: 10.1016/j.lanmic.2024.100956. Online ahead of print. Lancet Microbe. 2024. PMID: 39612921 Free article.
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pockets.
Schwalm MP, Dopfer J, Kumar A, Greco FA, Bauer N, Löhr F, Heering J, Cano-Franco S, Lechner S, Hanke T, Jaser I, Morasch V, Lenz C, Fearon D, Marples PG, Tomlinson CWE, Brunello L, Saxena K, Adams NBP, von Delft F, Müller S, Stolz A, Proschak E, Kuster B, Knapp S, Rogov VV. Schwalm MP, et al. Among authors: hanke t. Nat Commun. 2024 Nov 25;15(1):10204. doi: 10.1038/s41467-024-54409-5. Nat Commun. 2024. PMID: 39587067 Free PMC article.
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2.
Raig ND, Surridge KJ, Sanz-Murillo M, Dederer V, Krämer A, Schwalm MP, Elson L, Chatterjee D, Mathea S, Hanke T, Leschziner AE, Reck-Peterson SL, Knapp S. Raig ND, et al. Among authors: hanke t. bioRxiv [Preprint]. 2024 Oct 31:2024.09.17.613365. doi: 10.1101/2024.09.17.613365. bioRxiv. 2024. PMID: 39554022 Free PMC article. Preprint.
455 results